| DITPA | |
|
Description: A multi-center, randomized, double-blind, placebo-controlled study of DIPTA in patients with NYHA Class III and IV Congestive Heart Failure who have low serum T3 levels. Principal Investigator: Shelly Hall, M.D. Location: Heartplace Baylor Sub-Investigator: Johannes Kuiper, M.D. Primary Objective: To determine if Congestive Heart Failure patients with a specific thyroid (T3) deficiency would benefit from T3 supplemental medication. Contact Information: Cory White (214.820.7825) |
|
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
